More on ALXO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (8/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ALX Oncology (NQ:ALXO)
Delayed: 2.21 +0.08 (3.76%)
Prev. Close $2.13  
Open$2.16 
52 Wk High$ 
52 Wk Low$ 
Day High$2.36 
Day Low$2.13 
P/E N/A  
EPS$ 
Volume1,224,125 

Friends, Peers and Foes (?): ERAS, IMRX, ONCY PRLD (more...)

Mar 6, 2026 06:09 AM UBS Resumes ALX Oncology (ALXO) at Buy
Mar 5, 2026 04:05 PM Form 4 ALX ONCOLOGY HOLDINGS For: Mar 03 Filed by: Klencke Barbara
Mar 5, 2026 04:01 PM Form 3 ALX ONCOLOGY HOLDINGS For: Feb 25 Filed by: Klencke Barbara
Feb 27, 2026 08:59 AM ALX Oncology Holdings Inc. (ALXO) Misses Q4 EPS by 7c
Feb 27, 2026 08:05 AM Form 8-K ALX ONCOLOGY HOLDINGS For: Feb 27
Feb 27, 2026 08:00 AM ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 20, 2026 04:01 PM Form 4 ALX ONCOLOGY HOLDINGS For: Feb 18 Filed by: Pinto Shelly
Feb 19, 2026 09:02 PM Form 4 ALX ONCOLOGY HOLDINGS For: Feb 17 Filed by: Lettmann Jason
Feb 19, 2026 08:33 AM ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
Feb 19, 2026 08:30 AM ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
View All Articles

Entities mentioned with ALXO

View All Entities